It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Intellectual disability (ID) is a heterogeneous clinical entity and includes an excess of males who harbor variants on the X-chromosome (XLID). We report rare FAM50A missense variants in the original Armfield XLID syndrome family localized in Xq28 and four additional unrelated males with overlapping features. Our fam50a knockout (KO) zebrafish model exhibits abnormal neurogenesis and craniofacial patterning, and in vivo complementation assays indicate that the patient-derived variants are hypomorphic. RNA sequencing analysis from fam50a KO zebrafish show dysregulation of the transcriptome, with augmented spliceosome mRNAs and depletion of transcripts involved in neurodevelopment. Zebrafish RNA-seq datasets show a preponderance of 3′ alternative splicing events in fam50a KO, suggesting a role in the spliceosome C complex. These data are supported with transcriptomic signatures from cell lines derived from affected individuals and FAM50A protein-protein interaction data. In sum, Armfield XLID syndrome is a spliceosomopathy associated with aberrant mRNA processing during development.
Armfield X-linked disability (XLID) disorder has previously been linked to a locus in Xq28. Here, the authors report rare missense variants in FAM50A at Xq28, show that FAM50A interacts with the spliceosome, and that mis-splicing is enriched in knockout zebrafish suggesting it is a spliceosomopathy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




















1 Chungnam National University, Department of Biology, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
2 Duke University Medical Center, Center for Human Disease Modeling, Durham, USA (GRID:grid.189509.c) (ISNI:0000000100241216); Ann & Robert H. Lurie Children’s Hospital of Chicago, Advanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children’s Research Institute, Chicago, USA (GRID:grid.413808.6) (ISNI:0000 0004 0388 2248); National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Faisalabad, Pakistan (GRID:grid.419397.1) (ISNI:0000 0004 0447 0237); Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan (GRID:grid.420112.4) (ISNI:0000 0004 0607 7017)
3 Children’s Healthcare of Atlanta, Atlanta, USA (GRID:grid.428158.2) (ISNI:0000 0004 0371 6071)
4 Greenwood Genetic Center, Greenwood, USA (GRID:grid.418307.9) (ISNI:0000 0000 8571 0933)
5 Wellcome Sanger Institute, Hinxton, Cambridge, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382)
6 Institute of Cancer Research, Chester Beatty Laboratories, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1271 4623)
7 Clemson University, Department of Physics, Clemson, USA (GRID:grid.26090.3d) (ISNI:0000 0001 0665 0280)
8 A. I. duPont Hospital for Children, Division of Medical Genetics, Wilmington, USA (GRID:grid.239281.3) (ISNI:0000 0004 0458 9676)
9 Phoenix Children’s Medical Group, Genetics and Metabolism, Phoenix, USA (GRID:grid.239281.3)
10 McMaster University Medical Center, Clinical Genetics Program, Hamilton, Canada (GRID:grid.411657.0) (ISNI:0000 0001 0699 7567)
11 University of North Carolina School of Medicine, Division of Pediatric Genetics and Metabolism, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
12 Chungnam National University, Department of Microbiology and Molecular Biology, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
13 Korea Advanced Institute of Science and Technology, Department of Biological Sciences, Daejeon, Korea (GRID:grid.37172.30) (ISNI:0000 0001 2292 0500)
14 Duke University Medical Center, Center for Human Disease Modeling, Durham, USA (GRID:grid.189509.c) (ISNI:0000000100241216); Ann & Robert H. Lurie Children’s Hospital of Chicago, Advanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children’s Research Institute, Chicago, USA (GRID:grid.413808.6) (ISNI:0000 0004 0388 2248)
15 National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Faisalabad, Pakistan (GRID:grid.419397.1) (ISNI:0000 0004 0447 0237)
16 GeneDx Inc, Gaithersburg, USA (GRID:grid.428467.b)
17 Center for Rare Childhood Disorders, TGen, Phoenix, USA (GRID:grid.250942.8) (ISNI:0000 0004 0507 3225)
18 Duke University Medical Center, Center for Human Disease Modeling, Durham, USA (GRID:grid.189509.c) (ISNI:0000000100241216); Ann & Robert H. Lurie Children’s Hospital of Chicago, Advanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children’s Research Institute, Chicago, USA (GRID:grid.413808.6) (ISNI:0000 0004 0388 2248); Northwestern University, Department of Pediatrics, Feinberg School of Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)